Archer Materials LimitedASX: AXE

AXE partners with Hylid Diagnostics for Biochip development

· Issued by Archer Materials Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Archer Materials Limited has announced a partnership with Hylid Diagnostics to develop a Biochip for at-home testing of chronic kidney disease. The collaboration will combine Archer's potassium sensing technology with Hylid's blood hemolysis sensor technology to create a prototype system. The first phase involves producing stand-alone hemolysis sensors that will integrate with Archer's Biochip to meet accuracy requirements for potassium measurement. This partnership aims to enhance patient outcomes through effective at-home testing solutions.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Archer Materials Limited on 6ix

Story so far

Earlier from Archer Materials

Later from Archer Materials

All Archer Materials news releases